fightaging.org /1 week ago

The Double-Edged Sword of Therapy-Induced Senescence in Cancer Treatment

The dominant forms of cancer therapy, chemotherapy and radiotherapy, induce senescence in cancer cells they cannot kill, as well as in non-cancerous cells exposed to the treatment....

Read source
genengnews.com /1 month ago

How Cells Respond Differently to a Cancer-Causing Gene

Chemotherapies frequently cause cancer cells to enter senescence, but do not fully eliminate these cells. Therefore, it is useful to target these therapy-induced senescent cells wi...

Read source
scmp.com /1 month ago

Landmark China trial gets 84% efficacy in treating cancer with cue from waste water tech

For patients with advanced, metastatic cancer that has progressed despite systemic therapy – options remain critically limited. Now, Chinese scientists are pointing to an unconvent...

Read source
genengnews.com /1 week ago

Therapeutic Immune Manipulation

Next-generation immunotherapy exploits diverse immune populations to address the challenges that CAR T-cell therapy faces. The post Therapeutic Immune Manipulation appeared first o...

Read source
cafepharma.com /2 weeks ago

Chemotherapy Actually Helps Immunotherapy in Cancer

Chemotherapy Actually Helps Immunotherapy in Cancer Anonymous (not verified) Mon, 11/02/2026 - 18:25 pharmagather item url Chemotherapy Actually Helps Immu...

Read source
nytimes.com /1 month ago

A New World of Lung Cancer Therapy Awaits Pope Leo

Lung cancer is still a leading cause of cancer death, but that rate is half what it was in the 1990s, partly because newly developed treatments are working.

Read source
bioengineer.org /1 month ago

Gold Nanorods and Laser Light Strike at Cancer Stem Cells in Cats With Breast Tumors

In a veterinary clinic in Cairo, ten cats with spontaneous mammary carcinoma became the unlikely protagonists of a study that could reshape how aggressive breast cancers are monito...

Read source
sciencedaily.com /2 weeks ago

Scientists trick cancer cells into making the drugs that kill them

Scientists have developed a promising new cancer-fighting strategy that uses carbon monoxide naturally produced by tumor cells to manufacture powerful drugs inside the cancer cells...

Read source
bioengineer.org /3 weeks ago

Immune Cells That Sabotage Treatment: Th17 Signals Help Cervical Cancer Cells Survive Therapy

A laboratory study finds that Th17-derived IL-17 signaling activates AKT in cervical carcinoma cell lines, reducing their sensitivity to cisplatin, radiation, and combined chemorad...

Read source
scitechdaily.com /1 week ago

A New Approach Could Eliminate “Zombie” Cancer Cells That Survive Chemotherapy

Some cancer cells survive chemotherapy by blocking their own self-destruct system, but researchers have found a way to switch it back on and kill those cells. Chemotherapy can leav...

Read source
nytimes.com /1 month ago

New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.

Read source
aacr.org /1 month ago

HER2-targeted Therapy for Salivary Gland Cancer

Salivary gland cancer is rare, and there are no standard treatments for advanced-stage disease. Recent research supports the use of HER2-targeted therapy for patients with metastat...

Read source
bioengineer.org /2 weeks ago

Chinese Cancer Association issues unified guideline for tumor-related lung injury care

The Chinese Anti-Cancer Association has published an open access guideline standardizing diagnosis and treatment of respiratory injury caused by tumors and cancer therapies.

Read source
sciencedaily.com /1 month ago

Bowel cancer “melted away” after immunotherapy, then stayed away

A short course of immunotherapy before surgery may offer remarkably durable protection for some patients with stage two or three bowel cancer. In the NEOPRISM-CRC trial, 32 patient...

Read source
scitechdaily.com /3 weeks ago

Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside

Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have dev...

Read source
bioengineer.org /1 month ago

Staphylococcal Protein Reprograms Liver Tumor Macrophages to Boost Immunotherapy

One of the most stubborn obstacles in cancer immunotherapy is not the tumor cell itself but the cellular entourage that surrounds it. In hepatocellular carcinoma, the most common f...

Read source
aacr.org /2 weeks ago

Cracking “Undruggable” Cancer Proteins: Precision Oncology Meets p53

The development of KRAS inhibitors has ushered in a new era in precision oncology and renewed efforts in therapeutic targeting of p53, the most commonly altered gene in human cance...

Read source
bioengineer.org /1 month ago

Old Antabuse Drug Turns Breast Cancer Resistance Against Itself

Chemotherapy has long been a workhorse against metastatic breast cancer, yet for most patients with estrogen receptor-positive (ER+) disease, the cancer eventually wins the evoluti...

Read source
scitechdaily.com /4 weeks ago

MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer

Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune di...

Read source
scmp.com /2 weeks ago

Chinese drug iza-bren doubles lung cancer survival window in phase 3 trial

An anticancer drug developed by Sichuan Biokin Pharmaceutical took centre stage in a late-breaking oral presentation at the European Society for Medical Oncology (ESMO) Congress in...

Read source
singularityhub.com /1 month ago

Radical New Tactic Would Stop Deadly Cancers Before They Start

Cancer interception aims to prevent abnormal growths from developing into tumors. The post Radical New Tactic Would Stop Deadly Cancers Before They Start appeared first on Singula...

Read source
timesofindia.indiatimes.com /1 month ago

Stanford blood cancer transplant therapy reaches first commercial patient

In a remarkable advancement, Stanford researchers have unveiled Orca-T therapy, which has recently received FDA approval. After two decades of rigorous development, this innovative...

Read source
biopharmadive.com /5 days ago

CG Oncology drug delivers ‘exceptional’ results in key bladder cancer trial

CG’s therapy cretostimogene cut the risk of recurrence by 68% when administered after surgery, far surpassing Wall Street’s expectations and lifting company shares. 

Read source
peterattiamd.com /4 weeks ago

Personalized medicine comes to cancer immunotherapy

A phase III trial for personalized melanoma vaccination foreshadows a new era of cancer treatment The post Personalized medicine comes to cancer immunotherapy appeared first on Pe...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.